Magali Haas, MD, PhD

CEO & President

Dr. Haas founded Orion Bionetworks in July 2012 and serves as its CEO and President. Orion Bionetworks was transformed to Cohen Veterans Bioscience in 2015 to specifically dedicate research to improving the detection and treatment of post-traumatic stress (PTS) and traumatic brain injury (TBI) and related co-morbidities so that the burden of these conditions may be lessened on service members, veterans, and their families.

Magali has over 15 years of pharmaceutical executive and clinical research experience, predominantly at Johnson & Johnson, where she assumed broad end-to-end development leadership roles in medical marketing, full clinical development, early development, and translational and biomarker sciences in psychiatry and neurology. She successfully filed NDAs in the US and Europe for risperidone indications in Autism, Adolescent Schizophrenia, Juvenile Bipolar Disorder and Conduct Disorders. She also led Development Teams evaluating compounds for Depression, Neuropathic Pain, Epilepsy, and Migraine Disorder.

She served 3 years as Chief Science and Technology Officer for One Mind for Research, a nonprofit organization launched in May 2012 by Patrick J Kennedy. She orchestrated the launch of One Mind’s seminal programs, Apollo, an informatics research portal and, Gemini, an international TBI/PTSD research program.

As an “intrapreneur” at J&J she established the first Neuroscience Translational Medicine & Integrative Solutions department, and co-founded the first Companion Diagnostics Center of Excellence as well as J&J’s Healthcare Innovation team. She serves on several advisory boards including Brain Canada, Prophase, Pear Therapeutics, PAASP and IMEC for nanoelectronics.

Magali earned her BS in bioengineering from the University of Pennsylvania, an MS in biomedical engineering from Rutgers University, New Jersey, and her MD PhD with distinction in neuroscience from Albert Einstein College of Medicine, New York.

Allyson Gage, PhD

Chief Medical Officer

Dr. Allyson T. Gage is a neuroscientist and drug development executive, who has over 18 years of experience leading teams in all phases of clinical development. She has been responsible for the overall strategic
and clinical development of small molecules, biologics, and cellular therapies for the treatment of central nervous
system disorders, including depression, alcohol dependence, Alzheimer’s dementia, neuropathic pain, traumatic brain injury, and spinal cord injury. Allyson has a proven track record in partnering with therapeutic area clinicians, US and International regulators, patient groups, and data scientists to translate pre-clinical information into human evaluation, to design informative clinical trial protocols, and ensure a regulatory path with approvable and clinically meaningful outcome measures. Prior to joining Cohen Veterans Bioscience, Allyson’s most recent experience was focused in the field of regenerative medicine, working toward the development of a therapeutic for spinal cord injury.

Allyson earned her BA from Rutgers College in New Brunswick, NJ and her MS and PhD in neuroscience from Albert Einstein College of Medicine, New York.

Andreas Jeromin, PhD

Chief Scientific Officer

Andreas Jeromin, PhD, has established research programs in translational neuroscience in both industry and biotech for the last 15 years and co-authored more than 100 publications. He has also been elected a member of the Dana Alliance for Brain Initiatives. Andreas Jeromin has led biomarker qualification programs in diagnostics and therapeutics in acute neurological injury and neurodegeneration in roles with increased responsibilities. This included several drug development program from POC to a NINDS-supported phase III trial (Protect III). He also supports as member of the SABs or steering committee, several biomarker qualification efforts such as ADNI, the Coalition against Major Diseases (CAMD) directed by the Critical Path Institute (C-PATH), the Alzheimer’s Association CSF QC and biomarker assay standardization initiatives in other CNS disorders, including MS (Accelerated Cure), ALS and PD. He is the founder and CSO of Atlantic Biomarkers, LLC, and joined Quanterix, Inc. as scientific and medical advisor in 2014.

Lee Lancashire, PhD

Chief Information Officer

Lee Lancashire, PhD has over 15 years of experience in machine learning and statistics. His PhD was focused on the development of artificial neural network based methodologies where he was involved in many of the first applications of neural nets to high dimensional datasets in bioinformatics.

Prior to joining Cohen Veterans Bioscience, Lee spent over five years within the IP&Science business of Thomson Reuters where he established and led the machine learning and statistical data analysis team. Here he held global responsibility for managing and delivering analytical projects, serving the majority of the top 10 pharmaceutical companies, as well as government, academic and non-profit organizations. These projects focused on utilizing advanced machine learning approaches in the molecular profiling of disease for biomarker discovery, patient stratification and drug target identification.

Lee completed his post-doctoral research in Biostatistics and Bioinformatics at the Paterson Institute for Cancer Research, a Cancer Research UK core facility. He has also worked as a bioinformatics project lead in personalized medicine and diagnostics companies CompanDX and Almac Diagnostics. He has published in over 30 key industry journals and holds several patents around the use of neural networks in the biomedical domain.
In his free time Lee devotes time volunteering as a trustee for the Ichthyosis Support Group, a charity that supports individuals and families affected by a group of rare skin disorders.

Thomas P. Oberst

Chief Technology Officer (Consulting)

Thomas P. Oberst brings 35 years of computer systems experience in high tech and financial services, most recently as the CTO of Advanced Strategic Technology. He is providing vision and technical leadership in the area of Big Data and Cyber Security in support of Cohen Veterans Bioscience’s mission.

His career has spanned 20 years in high tech working, mostly in research and product development for startups which were later purchased by Hewlett Packard and EMC. His more recent career was spent working in the Enterprise Architecture and Technology Group at Fidelity Investments, where he helped design, develop, and deploy some of the most advanced systems used anywhere in Financial Services.

Tom has expertise in computer and server architecture, system design, development, systems engineering and deployment of secure, extremely scalable, globally deployable information infrastructure.

Tom earned his BS in Electrical Engineering from Union College, and Master Degrees in Computer Science and Business from Rensselaer Polytechnic Institute and the Harvard Business School.

Kristophe Diaz, PhD

Senior Manager,
Scientific Programs

After earning a doctorate in Molecular and Cellular Biology at the University of Massachusetts, Dr. Diaz investigated key mechanisms of cell division. He has also studied Life Science Innovation at Harvard Medical School and Business Law for Entrepreneurs at MIT Sloan School of Management.

Chantelle Ferland-Beckham, PhD

Senior Manager,
Scientific Programs

Dr. Chantelle Ferland-Beckham is a translational neuroscientist with over 12 years of experience in behavioral models of stress-related psychiatric disorders. The major goal of her research has been to develop animal models to investigate the complex molecular and epigenetic underpinnings of stress-induced pathology, including depression and post-traumatic stress disorder. She earned her PhD in Neuroscience from Tulane University under the mentorship of Dr. Laura Schrader and then went on to complete a postdoctoral fellowship at the Medical University of South Carolina, where she was awarded the Ruth L Kirschstein National Service Award (T32) from the National Institute of Drug Addiction to investigate the role of the endogenous oxytocin system in a model of comorbid methamphetamine addiction and post-traumatic stress disorder. Most recently, Chantelle was a AAAS Science & Technology Policy Fellow at the National Institutes of Health, where she worked as a Science Policy Analyst, developing policies to promote progress in biomedical research and serving as a legislative analyst to strengthen the relationship between the NIH and Congress. As a fellow, she worked on the Fellows in Innovation initiative, spearheaded by the Obama administration’s Office of Science and Technology Policy, to analyze current strategies and provide policy recommendations for suicide prevention in current and former members of the US military.

Heather Lasseter, PhD

Senior Manager,
Scientific Programs

Dr. Heather Lasseter earned her PhD from the University of North Carolina at Chapel Hill in the field of behavioral neuroscience. As a doctoral candidate in Dr. Rita Fuchs’ laboratory, Heather explored the neural circuity that regulates the ability of a drug-paired environmental context to produce cocaine-seeking behavior in a preclinical model of addiction. Her doctoral dissertation research – which earned the 2012 Linda Dykstra Distinguished Dissertation Award in Social Sciences – focused on the contribution of a mesocorticolimbic subcircuit to the reinstatement of cocaine seeking. After earning her doctoral degree, Heather was awarded a post-doctoral Health Communications Fellowship at the National Cancer Institute in the Division of Cancer Control and Population Sciences. She subsequently transitioned into the medical communications community as a Senior Medical Writer for Percolation Communications LLC, working within a number of therapeutic areas, including psychiatric and neurological disorders.

Thomas Nydam

Senior Director,
Clinical Programs

Thomas Nydam is a pharmaceutical clinical research professional with expertise in clinical development, clinical operations, and medical affairs, including experience in leading study teams, CROs, and multinational clinical trials. His background includes the drug development process, safety assessments, regulatory guidelines, and lifecycle management, with extensive experience in a broad range of disease indications, including oncology/hematology malignancies using antibodies, chemotherapy, small molecule, and targeted therapies.

Retsina Meyer, PhD

Senior Manager,
Clinical Programs

“Knowing is not enough; we must apply. Willing is not enough; we must do.”-Goethe

Dr. Retsina Meyer pairs pursuit of scientific endeavors with the passionate execution to make real her vision to develop cures for mental illness.

Dr. Meyer is a translational neuroscientist, scientific founder of Resilience – a startup focused on novel treatments for PTSD and other brain diseases, and is currently consulting Scientific Program Manager for Cohen Biosciences. An active member of the biotech entrepreneurship community, Retsina works on local, national, and international programming to inspire scientist-entrepreneurs. Dr. Meyer has produced over 40 articles, abstracts, and lectures. Her academic discoveries gained international press, earned her a speaking engagement at the local TEDx conference, and served as the instigating discovery to found Resilience.

As an entrepreneur, Retsina is an alumna of MassBIO’s MassCONNECT program and SpringBoard’s Life Sciences Accelerator and is the 2014 champion of the international OneStart competition awarded by GSK’s SR One.
She obtained a Neuroscience Ph.D. at MIT where she earned five named fellowships, was a Presidential Fellow, Imperial College of London Global Fellow, and a Graduate Woman of Excellence. She served as a science advocate with the Science Policy Initiative, performing outreach, giving lectures, and meeting with members of congress to appeal for science and scientific funding.
Prior to her work at MIT, Dr. Meyer was a Fulbright Scholar, serving as a representative of the U.S. to Norway, where she worked in the lab of 2014 Nobel Prize winners Drs. May-Britt Moser and Edvard Moser. She holds bachelor’s degrees in applied mathematics, biochemistry and molecular biophysics, and biopsychology from the University of Arizona where she was a Baver Scholar, and worked in the laboratories of Dr. David Rowe, Dr. Carol Barnes, and Dr. Bruce McNaughton.

Stephen Larson, PhD

Executive Director (Consulting),
BRAIN Commons

Stephen Larson is the CEO of MetaCell, global leaders in neuroscience software, with clients ranging from top-20 academic institutions to big pharma. He is a cofounder of the international OpenWorm project that is constructing a detailed digital simulation of a whole animal in an open science fashion. He has and co-developed a patent, presented at more than two dozen forums and published over a dozen articles in academic journals such as Nature and Frontiers in Neuroscience. Stephen has had his work featured in the Economist, the New York Times, Wired, the Atlantic, at two TEDx forums and a Science Channel show with Morgan Freeman. He holds a Bachelor and Masters from MIT in Computer Science with a focus on Artificial Intelligence and received a PhD in Neuroscience from the University of California, San Diego.

He previously served as the Chief Information Officer of One Mind for Research, a non-profit dedicated to eradicating brain disease through innovative public-private partnerships. He has worked as a professional software engineer for a major global investment bank He has served as a mentor in the Google Summer of Code program, a volunteer leader in the Startup Leadership Program, an entrepreneurial incubator, and the INCF, an international organization for coordinating the information science of neuroscience.

Deepti Cole

Associate Director,
Data Science

Deepti Cole is an informatics professional with more than ten years experience in the governance of biological and clinical data, supporting research through translational science, and leveraging open-source bioinformatics applications to deliver innovative and customized solutions.

As a former Data Scientist at Clarivate Analytics/Thomson Reuters she led numerous projects specializing in data and web-services integration and analytical pipeline designs. Her wide-ranging experience provides a balance of understanding the dynamics of operating in several fast-changing industries, along with the nuances of partnership rapport at all levels.

Deepti received her Master of Science degree in Bioinformatics from Boston University and began her career at Harvard and Partners Center for Genetics and Genomics, followed by The Jackson Laboratory. In her free time she spends time with her family and trains and competes with the Greater Boston Track Club, where she aims to improve her current personal best marathon time of 3:06.

Terri Gilbert, PhD

Engagement Director,
BRAIN Commons

Dr. Gilbert is a neuroscientist passionate about scientific communication, education and the open science movement. She has over 20 years’ experience effectively communicating high- level concepts to groups with a wide range of education and background, from non-scientific audiences to highly technical researchers. As the leader of outreach and training at the Allen Institute for Brain Science, she was an advocate for the user; including specifying friendly user interfaces, managing user support as well as launching their world-renowned educational programs. Her early experience researching the complex signal transduction mechanisms in G protein coupled receptors in both the immunological and neurological systems sparked her desire to share the elegance and beauty of complex systems, and to impart the joy of discovery to people around the world.

Dr. Gilbert obtained her PhD in Biomedical Sciences from the University of New Mexico School of Medicine, and her BS in Physics from the New Mexico Institute of Mining and Technology.

Daniela Brunner, PhD

Executive Director,
Digital Health

Dr. Brunner received her PhD from Cambridge University, did post-doctoral work at Columbia University, and had a lab at CUNY before joining PsychoGenics Inc. in 1999 as Director R&D, and later as Senior Vice President, until 2015. Dr. Brunner worked on developmental, psychiatric and neurodegenerative disease models for 20+ years; she introduced computer vision and machine learning techniques to the study of behavioral signatures for phenotyping, drug screening and systems biology projects. Working with the Tuberous Sclerosis Alliance, Dr. Brunner set up a consortium of industry and academia to accelerate the drug development for tuberous sclerosis. At Cohen Veterans Bioscience, Dr. Brunner is leading Digital Health programs focusing on data passively captured with wearable and home sensors.

Friso Postma, PhD

Senior Director,
Digital Health

Dr. Friso Postma has a masters in Medical Biology, University of Amsterdam, and a PhD on G-protein coupled receptor signaling and downstream cellular effectors, Netherlands Cancer Institute. As a post-doc at Harvard Medical School (Cambridge, MA) he used molecular and electrophysiological techniques to study the role of gap-junctions in the retina and CNS. As a Senior Scientist at Seaside Therapeutics (Cambridge MA) he worked on the development of treatments for fragile-X syndrome and Autism Spectrum Disorder. He continued his work as Associate Director of Electrophysiology at Psychogenics, a contract research organization, and as a scientific consultant for Boston-based biotech companies (SAGE therapeutics).

Udi Rubin

Data Science Director,
Digital Health

Udi Rubin worked for more than 10 years in the Israeli hi-tech industry. His experience alongside growing passion towards life sciences led Udi to pursue graduate studies in Biotechnology from Columbia University. In his research, Udi collaborated in developing data-driven computational frameworks for cancer genomics using topological data analysis and inferential statistics.

Nikolai Shokhirev, PhD

Senior Data Scientist,
Digital Health

Dr. Shokhirev received a Master of Science Degree in theoretical physics from Novosibirsk State University, Russia, and his Doctor of Philosophy degree in Physics and Mathematics from the Russian Academy of Sciences, Novosibirsk. Dr. Shokhirev has conducted research in quantum mechanics, magnetic spectroscopy, econophysics, stochastic processes and kinetics. He has also been involved in data analysis and processing in pulse spectroscopy, indirect measurements and remote sensing, scientific, engineering and financial data. He has published over 70 papers in those fields. Dr. Shokhirev joined the Digital Health team to apply his data science skills to the emerging area of remote health monitoring and healthcare.

Kevin Urban, PhD

Senior Data Scientist,
Digital Health

Kevin has over a decade of experience exploring a diverse range of complex data sets stemming from NASA and NOAA spacecraft missions in Earth’s ionosphere, magnetosphere, and interplanetary space, and from global-scale networks of ground-based instrumentation, and has leveraged this data to forecast space weather at the outer limits of Earth’s upper atmosphere and its effects in Earth’s polar cap regions, culminating in several peer-reviewed research papers. Kevin has also published on space mission design and dynamical system modeling of granular fluid systems. After receiving his PhD in physics from New Jersey Institute of Technology and Rutgers University, Kevin worked as a data scientist at WWE, where he built predictive models for subscriber behavior on the WWE Network (a monthly, direct-to-consumer, video streaming service averaging ~2 million daily active subscribers), and led various data engineering efforts, such as the collection, ingestion, and harmonization of WWE fan data across a host of social media and online platforms.

Carlos Espino García

Data Scientist,
Digital Health

Carlos received his Bachelor of Science in Applied Mathematics in 2012 from the Instituto Tecnológico Autónomo de México. Carlos then worked for Sinnia until 2015 and then joined the eScience Institute, University of Washington, as Data Science for Social Good Fellow, where he worked on data science projects using data from urban environments, public health, sustainable urban planning, crime prevention, education, transportation, and social justice. Carlos obtained a M. Sc. In Data Science from Columbia University in the City of New York in 2016.

Zhanna Rozenberg

Data Scientist,
Digital Health

Zhanna received her BA at Cornell University where she triple majored in Economics, Comparative Literature, and an College Scholars major that tread on philosophy, critical theory, and sociology. She completed a minor in East Asian Studies. She later went to study statistics, econometrics, and machine learning at the Ruprecht-Karls-Universität Heidelberg, Universität Mannheim, and the Metis’s data science bootcamp. Zhanna is interested in making technology that helps people live more meaningful lives, using data to improve human performance. Zhanna is active in NY’s meetup culture focusing on data science, neuroscience, wearables, IoT, and habit design. Zhanna’s major individual project, “Hindsight”, explored the interaction between subjective and objective measures of human performance.

Linda Dyson

Executive Director,
Public Affairs

Linda joins Cohen Veterans Bioscience with more than 30 years of experience across the entire health care spectrum. Linda has held leadership roles in both early-stage and established organizations, including with Nestlé S.A., Genentech, Roche and Pfizer Nutrition, where she was Global Communications Director, Commercial and R&D. Throughout her career she has helped launch more than 200 products, introduce corporate brands into new therapeutic areas and geographies, draft legislation and create public health initiatives to advance policy.

Linda’s experience includes more than two decades working in the central nervous system arena, highlighting clinical and regulatory milestones and working with organizations focused on traumatic brain injury, depression, anxiety, Alzheimer’s and Parkinson’s diseases, among other brain conditions.

Prior to her tenure at Pfizer Nutrition, Linda held a global leadership role in Roche Public Affairs as corporate spokesperson, responsible for external and executive communications, issues management, product commercialization, launch and licensing. Her remit included public policy across several franchises, as well as a focus on corporate branding and litigation communications.  Having established and led public affairs functions, Linda has engaged with policymakers, professional and patient advocacy groups on the local, national and global levels on issues related to access, funding and treatment guidelines, across hepatitis, HIV/AIDS, renal anemia, among many other conditions.

Linda holds a Master of Public Health Administration degree, with a focus in epidemiology, summa cum laude, from Suffolk University Sawyer School of Management, and a Bachelor of Arts degree in Political Science, concentration in French, from University of Pennsylvania.

Frank Larkin

Chair (Consulting),
Veterans Advisory Council

Frank Larkin was formerly the United States Senate Sergeant at Arms (SAA). As chief law enforcement and executive officer of the Senate, the SAA enforces rules of the Senate; provides a range of technical and administrative services to Senators in their Washington, DC, and state offices; and maintains security in the Capitol and Senate office buildings.

Frank was a member of the Senior Executive Service, recently serving as both the Acting Director and the Vice Director of the Joint Improvised Explosive Device Defeat Organization (JIEDDO) within the Department of Defense. He previously served as JIEDDO’s Director for the Counter IED Operations-Intelligence Integration Center. JIEDDO’s mission was to focus all Department of Defense actions in support of the combatant commanders’ efforts to defeat improvised explosive devices (IEDs) as weapons of strategic influence. Frank’s focus was in support of our deployed warfighters and special operations forces around the globe and the integration of a “whole of government” disruption effort targeting extremist networks that employ IEDs.

Frank served for more than two decades in the United States Secret Service (USSS), beginning in 1984 as a Special Agent assigned to the Philadelphia and Washington Field Offices, before assignment to the Presidential Protective Division. He was assigned to the Office of Congressional Affairs for a two-year fellowship on Capitol Hill, serving a year each with the Senate and House Appropriations Committees. Frank entered the USSS supervisory ranks as Assistant to the Special Agent in Charge of the New York Field Office, where he led financial, electronic, and organized crimes investigations. Following the events of 9/11, he returned to Washington, DC, as the Assistant Special Agent in Charge of the Presidential Protective Division, supervising White House security operations. As Assistant Special Agent in Charge of the Technical Security Division, Frank was responsible for tactical countermeasures programs. In 2004, he was promoted to the Senior Executive Service, assuming the position of Deputy Assistant Director for Protective Research and Chief Technology Officer.

Following his USSS career, Frank was Director, Program Management & Leadership, for the Raytheon Company, and more recently, worked at Lockheed Martin’s Defense & Intelligence Solutions, responsible for providing operations and intelligence analysis support to the intelligence community.

A veteran of the US Navy, Frank has a significant military and law enforcement special operations background, serving as a special warfare operator in the Navy SEALs. After his Navy service, he was a uniformed patrol officer with the Norristown (PA) Police Department, a homicide detective with the Montgomery County (PA) District Attorney’s Office, and a Maryland State Trooper-Flight Paramedic.

Frank holds a BA degree in criminal justice and an MS degree in public administration from Villanova University. He is the recipient of numerous awards, including the US Secret Service award for valor, the Department of the Army’s Exceptional Civilian Service award, and the Superior Civilian Service award.

Brian Losey, RADM, U.S. Navy (Ret.)

Executive Director (Consulting),
Veterans Advisory Council

Brian transitioned from 33 years of service in the U.S. Navy and Special Operations community in 2016.  He commanded U.S. Naval Special Warfare Command, U.S. Special Operations Command Africa, Combined Joint Task Force-Horn of Africa, Naval Special Warfare Development Group, and SEAL Delivery Vehicle Team ONE.  He served in key command and staff positions in Task Forces deployed to Afghanistan, Iraq, and Africa, and has significant experience in named and contingency operations around the world.  He served as a Director for Combatting Terrorism and Director for Maritime Security on the National Security Council Staff under the Bush and Obama Administrations.  Brian guides product and business development for Shield AI, a leading company in the fielding of autonomous and artificially intelligent robotic systems for the security sector.   In Commons Federated, LLC, Brian also serves as a consultant, advisor and board member to cutting edge technology enterprises seeking market growth in U.S. Government markets.

Nicole Harmon, PhD

Executive Director,
Community Partnerships

Nicole Harmon brings more than 18 years of experience in psychology, philanthropy, patient advocacy, public health, and clinical research, most recently as the Chief Operating Officer and Chief of Staff for Clinical Data Interchange Standards Consortium (CDISC), FDA’s partner for data standards. During her tenure there she transformed CDISC’s financial roadmaps, program management and global brand. Additionally, she developed and managed complex partnerships with leading U.S and International funding partners, U.S. FDA, Japan PMDA, European Medicines Agency, NIH, WHO, EU’s Innovative Medicines Initiatives, Global Patient Foundations and others to drive data standards and sharing initiatives and oversaw grants cultivation and management successfully achieving funding for and administering multiple large-scale projects.  Prior to her time with CDISC, Dr. Harmon evaluated patients with Traumatic Brain Injury and Psychiatric conditions in a post-acute rehabilitation hospital.

Nicole earned her doctorate in Counselor Education and Supervision at Texas Tech University with dissertation focus on understanding the caregivers experience associated with acquired brain injury following discharge from rehabilitation.

Nicole joins Cohen Veterans Bioscience to oversee development and engagement of strategic partnerships, grant management, events and the Brain Trauma Blueprint to further the Cohen Veterans Bioscience mission.

Dallas Hack, MD, Colonel, U.S. Army (Retired)

Veterans Science Strategy Advisor (Consulting)

Dr. Dallas Hack M.D. served as the Director of the US Army Combat Casualty Care Research Program and Chair of the Joint Program Committee for Combat Casualty Care from 2008 to 2014 and as the Senior Medical Advisor to the Principal Assistant for Research and Technology, US Army Medical Research and Materiel Command from 2014 to 2015. He coordinated more than 70% of the DoD trauma research to improve battlefield trauma care of those injured in combat. During this time, the Department of Defense funded more Traumatic Brain Injury research than any organization because of the increasing awareness of the massive burden of Traumatic Brain Injury in the military. He has held numerous military medical leadership positions including Chief of Clinical Services at Fort Knox, KY, Commander of the NATO Headquarters Healthcare Facility, and Command Surgeon at the strategic level during Operations Enduring Freedom and Iraqi Freedom. COL(R) Hack received numerous military awards including the Bronze Star, two Legion of Merit awards, and seven Meritorious Service Medals and was inducted as a Distinguished Member of the Military Order of Medical Merit. He has a BA from Andrews University, a MPH from Johns Hopkins University, a MD from Loma Linda University, a MSS from the US Army War College, and a CPE from the Certifying Commission in Medical Management. He was recognized as the Distinguished Alumnus of the Year by Loma Linda University in May 2015. After retiring from military service, Dr. Hack has consulted with numerous organizations to advance research in Brain Health and transition the progress to improved clinical practice.

Jessica Wolfe, PhD, MPH

Senior Clinical Advisor (Consulting),
Trauma Research Programs

Dr. Jessica Wolfe has been a behavioral researcher, neuropsychologist and executive in health sciences and public health for over 30 years.  She is currently a senior consultant to ESC (formerly Executive Service Corps), focusing on non-profit strategy and management and professional Research Associate at Harvard Medical School, Department of Physical Medicine and Rehabilitation.  Prior to that, she served as Senior Research Advisor to Spaulding Hospital Rehabilitation Network’s Institute of Lifestyle Medicine and Senior Research Program Advisor to Partners Healthcare System’s Center for Connected Health where she focused on clinical and research productivity involving wellness and technology innovation.

Jessica helped found the Department of Veterans Affairs (VA) National Center for PTSD where she subsequently developed and directed the National Center’s Women’s Health Sciences Division. There, she led competitively funded, large scale, research initiatives in war trauma, military sexual assault, and Gulf War illnesses.  She has over 70 peer-reviewed scientific publications.

Jessica received her Doctorate in clinical psychology from Columbia University.  She completed her Master’s in Public Health from Harvard University (HSPH).  Other interests include interactive health technologies, user-centered design (UX), neuroimaging in PTSD and traumatic brain injury (TBI), and stress adaptation across the lifespan.